Literature DB >> 9453829

[Human herpesvirus 8 and associated diseases: Kaposi's sarcoma, body cavity based lymphoma and multicentric Castleman disease: clinical and molecular epidemiology].

A Gessain1.   

Abstract

A new human virus belonging to the herpesvirinae family was recently isolated and characterized. This virus called human herpesvirus 8 is considered as the etiological agent or as a major cofactor of all the clinical forms (HIV associated or not) of Kaposi's sarcoma. HHV8 is also associated with rare B cell lymphomas called body cavity based lymphoma (BCBL) or Primary effusion lymphoma (PEL) occurring in the body cavities mainly in AIDS patients and of some cases of the multicentric form of Castleman's disease. Only preliminary data are available on the epidemiological characteristics (modes of transmission in endemic regions, geographical distribution ...) of the HHV8 infection but should rapidly beneficiate of the establishment of specific and reliable serological tests. Nevertheless, it appears that the HHV8 seroprevalence is very high (15 to 50%) in the adult general population of areas having a high incidence of Kaposi's sarcoma as some east african countries and at a lesser extend as some mediterranean areas as southern Italy or Greece. In the occidental world, the seroprevalence of HHV8 seems very low (0 to 5% in the blood donors) except in some populations at risk for sexually transmitted diseases especially in the homosexual male group. Preliminary data indicate the existence of a low genetic variability of HHV8 in several regions of its genome, with however the presence of molecular subtypes linked possibly to the geographical origin of the infected patients.

Entities:  

Mesh:

Year:  1997        PMID: 9453829

Source DB:  PubMed          Journal:  Bull Acad Natl Med        ISSN: 0001-4079            Impact factor:   0.144


  3 in total

1.  Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.

Authors:  A J Aguirre; E S Robertson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders.

Authors:  M-Q Du; C M Bacon; P G Isaacson
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

3.  Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome.

Authors:  Noriko Iwaki; Yuka Gion; Eisei Kondo; Mitsuhiro Kawano; Taro Masunari; Hiroshi Moro; Koji Nikkuni; Kazue Takai; Masao Hagihara; Yuko Hashimoto; Kenji Yokota; Masataka Okamoto; Shinji Nakao; Tadashi Yoshino; Yasuharu Sato
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.